Clever Leaves (CLVR) Competitors $0.0002 0.00 (0.00%) As of 04/29/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock CLVR vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Clever Leaves stock or one of its competitors? The main competitors of Clever Leaves include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Clever Leaves vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity 180 Life Sciences (NASDAQ:ATNFW) and Clever Leaves (NASDAQ:CLVR) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, community ranking, valuation and earnings. Which has higher earnings & valuation, ATNFW or CLVR? 180 Life Sciences has higher earnings, but lower revenue than Clever Leaves. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AClever Leaves$17.42M0.00-$17.90M-$11.310.00 Does the media favor ATNFW or CLVR? In the previous week, 180 Life Sciences had 2 more articles in the media than Clever Leaves. MarketBeat recorded 2 mentions for 180 Life Sciences and 0 mentions for Clever Leaves. 180 Life Sciences' average media sentiment score of 1.24 beat Clever Leaves' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Positive Clever Leaves Neutral Does the MarketBeat Community believe in ATNFW or CLVR? Clever Leaves received 13 more outperform votes than 180 Life Sciences when rated by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/AClever LeavesOutperform Votes1381.25% Underperform Votes318.75% Is ATNFW or CLVR more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Clever Leaves N/A N/A N/A Do institutionals and insiders believe in ATNFW or CLVR? 6.9% of Clever Leaves shares are held by institutional investors. 8.2% of Clever Leaves shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryClever Leaves beats 180 Life Sciences on 4 of the 6 factors compared between the two stocks. Get Clever Leaves News Delivered to You Automatically Sign up to receive the latest news and ratings for CLVR and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLVR vs. The Competition Export to ExcelMetricClever LeavesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$6.89B$5.56B$7.83BDividend YieldN/A3.05%5.11%4.22%P/E Ratio0.007.4422.4818.48Price / Sales0.00242.70394.56103.59Price / CashN/A65.8538.1834.62Price / Book0.006.516.774.25Net Income-$17.90M$143.21M$3.22B$248.23M7 Day PerformanceN/A1.98%1.48%0.89%1 Month PerformanceN/A6.89%3.99%3.53%1 Year PerformanceN/A-2.52%16.15%5.08% Clever Leaves Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLVRClever LeavesN/A$0.00flatN/A-100.0%$0.00$17.42M0.00560ATNFW180 Life SciencesN/A$0.01-4.2%N/A-11.8%$0.00N/A0.007News CoverageLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01-10.0%N/AN/A$0.00N/A0.002Gap DownAIMDWAinosN/A$0.10-5.9%N/AN/A$0.00$20,729.000.0040Gap DownALVOWAlvotechN/A$1.28-7.9%N/A-59.3%$0.00$489.68M0.004Short Interest ↑News CoverageGap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02flatN/A-76.3%$0.00N/A0.0015BFRIWBiofronteraN/A$0.05flatN/AN/A$0.00$37.32M0.0070BTMDWbioteN/A$0.02-5.1%N/A-89.9%$0.00$197.19M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.12-9.6%N/A-86.8%$0.00N/A0.008Gap UpCELUWCelularityN/A$0.04-8.5%N/A+14.0%$0.00$48.20M0.00220Gap Down Related Companies and Tools Related Companies ATNFW Alternatives LBPSW Alternatives AEHAW Alternatives AIMDW Alternatives ALVOW Alternatives ACABW Alternatives BFRIW Alternatives BTMDW Alternatives BCTXW Alternatives CELUW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLVR) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clever Leaves Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clever Leaves With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLVR Stock Free CLVR Stock Alerts